Surgery Partners (SGRY) Scheduled to Post Earnings on Tuesday

Surgery Partners (NASDAQ:SGRY - Get Free Report) will be posting its quarterly earnings results before the market opens on Tuesday, November 12th. Analysts expect Surgery Partners to post earnings of $0.21 per share for the quarter. Persons that are interested in registering for the company's earnings conference call can do so using this link.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its earnings results on Tuesday, August 6th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.01. The firm had revenue of $762.10 million for the quarter, compared to the consensus estimate of $735.94 million. Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%. The business's revenue was up 14.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.25 earnings per share. On average, analysts expect Surgery Partners to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Surgery Partners Stock Up 1.7 %

Shares of SGRY traded up $0.50 on Tuesday, hitting $29.72. 355,963 shares of the stock traded hands, compared to its average volume of 923,640. Surgery Partners has a one year low of $22.25 and a one year high of $36.92. The company has a market capitalization of $3.78 billion, a PE ratio of -110.07, a P/E/G ratio of 2.23 and a beta of 2.76. The business has a 50 day simple moving average of $31.15 and a 200 day simple moving average of $28.30. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.69 and a current ratio of 1.83.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Benchmark restated a "buy" rating and issued a $50.00 price target on shares of Surgery Partners in a research note on Monday, August 26th. Royal Bank of Canada restated an "outperform" rating and issued a $49.00 price target on shares of Surgery Partners in a research note on Wednesday, August 7th. UBS Group assumed coverage on Surgery Partners in a research note on Monday, October 14th. They issued a "buy" rating and a $38.00 price target for the company. KeyCorp assumed coverage on Surgery Partners in a research note on Friday, October 11th. They issued a "sector weight" rating for the company. Finally, Cantor Fitzgerald reiterated an "overweight" rating and set a $43.00 price objective on shares of Surgery Partners in a research report on Friday, October 4th. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, Surgery Partners presently has an average rating of "Moderate Buy" and a consensus target price of $40.13.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.